Yen‐Shen Lu
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
Papers in
- Oncology 139
- Cancer Treatment and Pharmacology 58
- HER2/EGFR in Cancer Research 48
- Lung Cancer Research Studies 22
- Cancer-related Molecular Pathways 16
-
- Advanced Breast Cancer Therapies 80
- Co-authors
- Ann‐Lii Cheng (78 shared papers)Ching‐Hung Lin (76 shared papers)Chiun‐Sheng Huang (49 shared papers)Fabrice André (14 shared papers)Toshinari Yamashita (9 shared papers)Hiroji Iwata (8 shared papers)Zsuzsanna Pápai (6 shared papers)Mario Campone (8 shared papers)
- Journals
- Cancer Research (27 papers)Journal of Clinical Oncology (24 papers)Annals of Oncology (24 papers)The Oncologist (7 papers)Breast Cancer Research and Treatment (7 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Yen‐Shen Lu
222 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 2.1k
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 2.6k
- Genetics 754
- Pathology and Forensic Medicine 653
Countries citing papers authored by Yen‐Shen Lu
This map shows the geographic impact of Yen‐Shen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Shen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Shen Lu more than expected).
Fields of papers citing papers by Yen‐Shen Lu
This network shows the impact of papers produced by Yen‐Shen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Shen Lu. The network helps show where Yen‐Shen Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yen‐Shen Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2019 | 1565 |
| 2 | Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer Hit paper breakdown → | 2019 | 591 |
| 3 | Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1 Hit paper breakdown → | 2020 | 371 |
| 4 | 2002 | 129 | |
| 5 | 2008 | 128 | |
| 6 | 2008 | 105 | |
| 7 | 2009 | 104 | |
| 8 | 2019 | 104 | |
| 9 | 2013 | 96 | |
| 10 | 2011 | 94 | |
| 11 | 2008 | 94 | |
| 12 | 2007 | 82 | |
| 13 | 2019 | 82 | |
| 14 | 2021 | 79 | |
| 15 | 2009 | 78 | |
| 16 | 2020 | 76 | |
| 17 | 2015 | 71 | |
| 18 | 2016 | 69 | |
| 19 | 2004 | 66 | |
| 20 | 2014 | 66 |
About Yen‐Shen Lu
Yen‐Shen Lu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Genetics, having authored 238 papers that have together received 6.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (80 papers), Cancer Treatment and Pharmacology (58 papers), HER2/EGFR in Cancer Research (48 papers), Breast Cancer Treatment Studies (38 papers), Lung Cancer Research Studies (22 papers), Cancer Genomics and Diagnostics (17 papers), Estrogen and related hormone effects (16 papers) and Cancer-related Molecular Pathways (16 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (3.3k citations), Pulmonary and Respiratory Medicine (2.6k citations), Genetics (754 citations) and Pathology and Forensic Medicine (653 citations). Yen‐Shen Lu has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Ann‐Lii Cheng, Ching‐Hung Lin, Chiun‐Sheng Huang, Fabrice André, Toshinari Yamashita, Hiroji Iwata, Zsuzsanna Pápai, Mario Campone, Bella Kaufman and Sibylle Loibl. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, The Oncologist and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.